SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
1.330
+0.040 (3.10%)
Apr 23, 2025, 4:00 PM EDT - Market closed
SLS Employees
SELLAS Life Sciences Group had 15 employees as of December 31, 2024. The number of employees decreased by 1 or -6.25% compared to the previous year.
Employees
15
Change (1Y)
-1
Growth (1Y)
-6.25%
Revenue / Employee
n/a
Profits / Employee
-$2,058,733
Market Cap
119.01M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
SLS News
- 17 hours ago - SELLAS to Present at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 15 days ago - SELLAS Announces Positive Overall Survival in Cohort 3 from the Ongoing Phase 2 Trial of SLS009 in r/r AML - GlobeNewsWire
- 23 days ago - Sellas Life Sciences: A Hold For Now With Huge, But Uncertain, Near-Term Catalyst - Seeking Alpha
- 4 weeks ago - SELLAS Life Sciences Reports Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - SELLAS Announces Positive Data from Phase 2a Trial of SLS009 in Combination with Zanubrutinib in DLBCL - GlobeNewsWire
- 3 months ago - SELLAS Life Sciences Group Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 3 months ago - SELLAS Life Sciences Announces Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia - GlobeNewsWire
- 3 months ago - SELLAS Announces Key Business Objectives for 2025 - GlobeNewsWire